Upstream Bioprocessing Update

CELL AND GENE THERAPY INSIGHTS

Upstream Bioprocessing Update

March 2019
Upstream Bioprocessing Update
Download PDF

Editorial

Manufacturing of genetically modified autologous T cells: key considerations for process development

Manufacturing of genetically modified autologous T cells: key considerations for process development

Mamta Kalra, Ali Mohamed
26 April 2019
Read

Expert Insight

Bioprocessing & biological challenges of large-scale red blood cell production from pluripotent stem cells: important factors to consider

Bioprocessing & biological challenges of large-scale red blood cell production from pluripotent stem cells: important factors to consider

Steve Oh, Jaichandran Sivalingam
9 May 2019
Read

Commentary

Key success criteria and factors for delivering scalable cell therapy upstream bioprocesses

Key success criteria and factors for delivering scalable cell therapy upstream bioprocesses

Gautam Banik
26 April 2019
Read
Creating a cell-friendly microenvironment to enhance cell culture efficiency

Creating a cell-friendly microenvironment to enhance cell culture efficiency

Ou Wang, Yuguo Lei
26 April 2019
Read

Interview

Challenges in upstream bioprocess development for viral vector production

Challenges in upstream bioprocess development for viral vector production

Ankita Desai, Philipp Nold
28 May 2019
Read
Determining the optimal culture system for your scale up strategy

Determining the optimal culture system for your scale up strategy

Marco Koppe, Clive Glover
20 May 2019
Read
A 3D vision for the future of tissue engineering

A 3D vision for the future of tissue engineering

Suwan N Jayasinghe
26 April 2019
Read

Podcast

Determining the optimal culture system for your scale up strategy

Determining the optimal culture system for your scale up strategy

Marco Koppe, Clive Glover
28 May 2019
Listen